← Back to Search

Fractional CO2 Laser

Single group 30 post menopause females. for Vulvovaginal Atrophy

N/A
Waitlist Available
Research Sponsored by SHERRY Thomas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 month
Awards & highlights

Study Summary

To assess the feasibility and efficacy of the CO2 fractional handpiece in the treatment of vulvovaginal atrophy (VVA) in post-menopausal women and its effect on the patient VHIS(vaginal health index core). The primary endpoint is to assess the change in the vaginal dryness by means of a visual analogic scale (10 cm VAS).

Eligible Conditions
  • Vulvovaginal Atrophy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fractional handpiece with CO2 laser: Fractional Ablative laser Treatment of Vulvovaginal Atrophy (VVA).

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single group 30 post menopause females.Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

SHERRY ThomasLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
Perigree MedicalUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby May 2025